GENERAL PELVIC ORGAN PROLAPSE: cost and payments to doctors
What Medicare Part D paid pharmacies for GENERAL PELVIC ORGAN PROLAPSE, and the payments that named it as the associated device or medical supply under the Sunshine Act for program years 2019–2025.
Was your doctor paid by Boston Scientific?
Boston Scientific reported the most payments naming GENERAL PELVIC ORGAN PROLAPSE. Search your clinician to see whether they are among them — and what else they were paid for.
Finding a payment is not a finding of wrongdoing — most reported payments are a meal during a presentation. What matters is the kind, the size, and how it compares with their peers, which is what the profile shows.
- Total reported
- $669K
- Providers
- 389
- Transactions
- 682
- Average per transaction
- $981
The per-transaction average — $981 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 389 providers the average total is $1,719, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Boston Scientific | $668,761 | 100.0% |
Other products from Boston Scientific
The company that reported the most payments naming GENERAL PELVIC ORGAN PROLAPSE also reports against these.
- GENERAL - THERAPIES$140,892,720
- SQ RX PULSE GENERATOR$16,181,746
- GENERAL EP$12,271,272
- WATCHMAN Access System$12,243,780
- Watchman$9,662,966
- GENERAL ERECTILE DYSFUNCTION$7,660,169
- GENERAL TACHY$7,300,552
- WaveWriter Alpha Prime 16$6,894,029
- Farapulse$6,139,604
- GENERAL - STRUCTURAL HEART$5,662,216